Scarica l'app Stockscreener
93.50
2.27%
-2.17
Pre-mercato:
93.43
-0.07
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$95.67
Aprire:
$95.47
Volume 24 ore:
7.75M
Relative Volume:
0.93
Capitalizzazione di mercato:
$119.30B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
41.06
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
-10.46%
1M Prestazione:
-10.23%
6M Prestazione:
+21.40%
1 anno Prestazione:
+44.11%
Intervallo 1D:
$93.01
$96.36
Intervallo di 1 settimana:
$93.01
$101.00
Portata 52W:
$64.32
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
93.50 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
402.19 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
390.37 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
273.87 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
372.82 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Wedge Capital Management L L P NC Has $31.23 Million Position in CVS Health Corporation $CVS - MarketBeat
E. Ohman J or Asset Management AB Decreases Holdings in CVS Health Corporation $CVS - MarketBeat
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
News by ACCESS Newswire on TradingView, 2026-08-11 - TradingView
Handelsbanken Fonder AB Buys 496,124 Shares of CVS Health Corporation $CVS - MarketBeat
Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration - Yahoo Finance
CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold' (NYSE:CVS) - Seeking Alpha
Elizabeth Warren Vows to Break the Monopoly of UnitedHealth Group, CVS Health and Cigna: 'I Have a Bill t - Benzinga
Vertrix Wealth Management LLC Invests $3.79 Million in CVS Health Corporation $CVS - MarketBeat
NewEdge Advisors LLC Grows Stake in CVS Health Corporation $CVS - MarketBeat
Oliver Luxxe Assets LLC Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Upgraded at Wall Street Zen - MarketBeat
CVS Health explained: pharmacy, insurance, and health services - qz.com
CVS pharmacy workers in Rhode Island stage walkout over staffing levels - The Business Journals
CVS Health Corporation $CVS Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Czech National Bank Raises Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp (CVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CVS Health (CVS) Stock Gets Fair Value Bump As Analysts Turn More Constructive - Yahoo Finance
CVS Health Corp (NYSE: CVS) files Form 13F with 21 reported holdings - Stock Titan
CVS Health Beats Q2 Expectations as Revenues Top $106B - storebrands.com
CVS Health Q2 Earnings Call Highlights - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Hamlin Capital Management LLC - MarketBeat
A Look at CVS Health Corp (CVS) After 5.1% Decline -- GF Value $77.71 vs Price $99.12 - GuruFocus
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Health Corporation (CVS) Stock Forecasts - Yahoo Finance
CVS Health Earnings: Aetna Margin Improvement Boosts 2026 Outlook - Morningstar
CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ... - Yahoo Finance
CVS posts sharply improved Q2, details GLP-1 market share plan - The Business Journals
CVS Health (NYSE:CVS) Posts Quarterly Earnings Results, Beats Expectations By $0.72 EPS - MarketBeat
CVS Health Corp Stock (CVS) Moved Down by 4.65% on Aug 5: Drivers Behind the Movement - TradingKey
CVS enhances supports for patients taking GLP-1s - Fierce Healthcare
CVS Health Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
CVS profit outlook overshadows strong quarter, shares fall - Reuters
CVS Health (NYSE:CVS) Shares Gap DownHere's What Happened - MarketBeat
CVS earnings boosted by Aetna as Caremark membership slips - Modern Healthcare
CVS Health Stock Is Falling Wednesday: What's Going On?CVS Health (NYSE:CVS) - Benzinga
Earnings call transcript: CVS Health beats Q2 2026 estimates but shares fall premarket - Investing.com
CVS falls after preliminary 2027 guidance disappoints - Modern Healthcare
CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs - Yahoo Finance
CVS Falls After Preliminary 2027 Guidance Disappoints - Yahoo Finance
Q2 2026 CVS Health Corp Earnings Call Transcript - GuruFocus
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Is CVS Health Corp (CVS) Overvalued After Q2 Earnings Beat? EPS of $2.31 Exceeds Estimates, GF Score: 75/100 - GuruFocus
CVS Health Corp earnings beat by $0.75, revenue topped estimates - Investing.com
[10-Q] CVS HEALTH Corp Quarterly Earnings Report - Stock Titan
CVS raises its 2026 profit outlook after quarterly EPS reaches $2.58 - Stock Titan
CVS and Lilly plan same-day Zepbound pickup by early Q4 - Stock Titan
36,217 Shares in CVS Health Corporation $CVS Acquired by Canandaigua National Bank & Trust Co. - MarketBeat
CVS Health enhances its direct-to-consumer weight management offerings - CVS Health
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cvs Health Corp Azioni (CVS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
1.84%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):